← Open Payments lookup

DEBBY CARL: Open Payments

NPI 1891147104 · FORDLAND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$760 in 42 payments from 14 companies in 2025. Trend: 2023 $616 · 2024 $858 · 2025 $760

Food & beverage: $760
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$199
Novo Nordisk Inc7$117
Otsuka America Pharmaceutical, Inc.5$110
ABBVIE INC.3$61
Insulet Corporation2$47
AstraZeneca Pharmaceuticals LP3$42
E.R. Squibb & Sons, L.L.C.2$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$31
Lundbeck LLC2$31
Globus Medical, Inc.1$19

Products named: INGREZZA, REXULTI, Ozempic, VRAYLAR, Omnipod, COBENFY, XIFAXAN, AIRSUPRA.

Industry payments across MO — which companies pay providers there.